2024 annual financial data

Eloxx Pharmaceuticals 2024 Financial results

Direct answer

Revenue was 6.36M USD.

Operating income was -2.47M USD and net income was -3.14M USD.
Operating cash flow was -4.72M USD.

Get free Eloxx Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
6.36M USD
Operating income
-2.47M USD
Net income
-3.14M USD
Operating cash flow
-4.72M USD